{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T22:55:22Z","timestamp":1777416922276,"version":"3.51.4"},"reference-count":33,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales d'Endocrinologie"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.ando.2018.08.002","type":"journal-article","created":{"date-parts":[[2018,8,18]],"date-time":"2018-08-18T15:57:27Z","timestamp":1534607847000},"page":"608-617","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Diagnostic procedure in suspected Graves\u2019 disease"],"prefix":"10.1016","volume":"79","author":[{"given":"Bernard","family":"Goichot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence","family":"Leenhardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Massart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00e9ronique","family":"Raverot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Tramalloni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hinde","family":"Iraqi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ando.2018.08.002_bib0175","series-title":"Diagnostic et surveillance biologiques de l\u2019hyperthyro\u00efdie de l\u2019adulte. Recommandations pour la pratique clinique (Laboratory diagnosis and monitoring of hyperthyroidism in adults. Clinical practice guidelines)","year":"2000"},{"key":"10.1016\/j.ando.2018.08.002_bib0180","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1089\/thy.2016.0229","article-title":"2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis","volume":"26","author":"Ross","year":"2016","journal-title":"Thyroid"},{"key":"10.1016\/j.ando.2018.08.002_bib0185","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1373\/clinchem.2016.269456","article-title":"Harmonization of serum thyroid-stimulating hormone measurements paves the way for the adoption of a more uniform reference interval","volume":"63","author":"Thienpont","year":"2017","journal-title":"Clin Chem"},{"key":"10.1016\/j.ando.2018.08.002_bib0190","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.beem.2013.10.003","article-title":"Pitfalls in the measurement and interpretation of thyroid function tests","volume":"27","author":"Koulouri","year":"2013","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2018.08.002_bib0195","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1515\/cclm-2015-0350","article-title":"Anti-streptavidin interferences in Roche thyroid immunoassays: a case report","volume":"54","author":"Peltier","year":"2016","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.ando.2018.08.002_bib0200","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.5858\/arpa.2012-0270-CR","article-title":"Interference from anti-streptavidin antibody","volume":"137","author":"Rulander","year":"2013","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.ando.2018.08.002_bib0205","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1089\/thy.2015.0664","article-title":"Misdiagnosis of Graves\u2019 disease with apparent severe hyperthyroidism in a patient taking biotin megadoses","volume":"26","author":"Barbesino","year":"2016","journal-title":"Thyroid"},{"key":"10.1016\/j.ando.2018.08.002_bib0210","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/PAT.0b013e3283514002","article-title":"Biotin interference on TSH and free thyroid hormone measurement","volume":"44","author":"Kwok","year":"2012","journal-title":"Pathology"},{"key":"10.1016\/j.ando.2018.08.002_bib0215","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1093\/clinchem\/34.12.2589","article-title":"Escape from blockade of interfering heterophile antibodies in a two-site immunoradiometric assay for thyrotropin","volume":"34","author":"Zweig","year":"1988","journal-title":"Clin Chem"},{"key":"10.1016\/j.ando.2018.08.002_bib0220","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0140-6736(79)90696-2","article-title":"Heterophilic antibodies causing falsely raised thyroid-stimulating-hormone result","volume":"2","author":"Hedenborg","year":"1979","journal-title":"Lancet"},{"key":"10.1016\/j.ando.2018.08.002_bib0225","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1093\/clinchem\/44.3.440","article-title":"Antibody interference in thyroid assays: a potential for clinical misinformation","volume":"44","author":"Despr\u00e9s","year":"1998","journal-title":"Clin Chem"},{"key":"10.1016\/j.ando.2018.08.002_bib0230","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1210\/jc.2011-3490","article-title":"Macro-thyrotropin: a case report and review of literature","volume":"97","author":"Loh","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2018.08.002_bib0235","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1177\/0004563213476271","article-title":"An immunoglobulin G complexed form of thyroid-stimulating hormone (macro thyroid-stimulating hormone) is a cause of elevated serum thyroid-stimulating hormone concentration","volume":"50","author":"Mills","year":"2013","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.ando.2018.08.002_bib0240","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1258\/acb.2010.010160","article-title":"Interference by antiruthenium antibodies in the Roche thyroid-stimulating hormone assay","volume":"48","author":"Buijs","year":"2011","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.ando.2018.08.002_bib0245","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1515\/cclm-2014-0067","article-title":"Anti-ruthenium antibodies mimic macro-TSH in electrochemiluminescent immunoassay","volume":"52","author":"Gessl","year":"2014","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.ando.2018.08.002_bib0250","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1515\/CCLM.2011.639","volume":"49","author":"Van Houcke","year":"2011","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.ando.2018.08.002_bib0255","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1373\/clinchem.2017.274407","article-title":"Standardization of free thyroxine measurements allows the adoption of a more uniform reference interval","volume":"63","author":"De Grande","year":"2017","journal-title":"Clin Chem"},{"key":"10.1016\/j.ando.2018.08.002_bib0260","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1373\/clinchem.2007.099770","article-title":"Influence of thyroid hormone autoantibodies on 7 thyroid hormone assays","volume":"54","author":"Zouwail","year":"2008","journal-title":"Clin Chem"},{"key":"10.1016\/j.ando.2018.08.002_bib0265","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.cca.2008.11.001","article-title":"Anti-thyroxine and anti-triiodothyronine antibody interferences in one-step free triiodothyronine and free thyroxine immunoassays","volume":"401","author":"Massart","year":"2009","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.ando.2018.08.002_bib0270","first-page":"90","article-title":"Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves\u2019 disease","volume":"84","author":"Costagliola","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ando.2018.08.002_bib0280","first-page":"221","article-title":"TSH-receptor antibodies: immunoanalytical characteristics","volume":"73","author":"Massart","year":"2015","journal-title":"Ann Biol Clin (Paris)"},{"key":"10.1016\/j.ando.2018.08.002_bib0285","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1373\/clinchem.2013.202747","article-title":"Thyroid-stimulating hormone receptor antibody assays: recommendation for correct interpretation of results in Graves\u2019 disease","volume":"59","author":"Massart","year":"2013","journal-title":"Clin Chem"},{"key":"10.1016\/j.ando.2018.08.002_bib0290","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.autrev.2012.07.003","article-title":"TSH receptor autoantibody immunoassay in patients with Graves\u2019 disease: improvement of diagnostic accuracy over different generations of methods. Systematic review and meta-analysis","volume":"12","author":"Tozzoli","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.ando.2018.08.002_bib0295","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1530\/eje.0.1410332","article-title":"Standardized grey scale ultrasonography in Graves\u2019 disease: correlation to autoimmune activity","volume":"141","author":"Schiemann","year":"1999","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2018.08.002_bib0300","doi-asserted-by":"crossref","first-page":"781","DOI":"10.2214\/ajr.150.4.781","article-title":"Color-flow Doppler sonography in Graves\u2019 disease: \u201cthyroid inferno\u201d","volume":"150","author":"Ralls","year":"1988","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.ando.2018.08.002_bib0305","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0720-048X(00)00147-9","article-title":"Color Doppler measurement of blood flow in the inferior thyroid artery in patients with autoimmune thyroid diseases","volume":"36","author":"Caruso","year":"2000","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.ando.2018.08.002_bib0310","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1089\/thy.2013.0257","article-title":"The epidemic of thyroid cancer in the United States: the role of endocrinologists and ultrasounds","volume":"24","author":"Udelsman","year":"2014","journal-title":"Thyroid"},{"key":"10.1016\/j.ando.2018.08.002_bib0315","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1089\/thy.2013.0045","article-title":"The increasing incidence of thyroid cancer: the influence of access to care","volume":"23","author":"Morris","year":"2013","journal-title":"Thyroid"},{"key":"10.1016\/j.ando.2018.08.002_bib0320","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.1210\/jc.2012-2802","article-title":"A 2011 survey of clinical practice patterns in the management of Graves\u2019 disease","volume":"97","author":"Burch","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2018.08.002_bib0325","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/cen.12688","article-title":"A 2013 European survey of clinical practice patterns in the management of Graves\u2019 disease","volume":"84","author":"Bartanela","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2018.08.002_bib0330","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000453260","article-title":"Survey of clinical practice patterns in the management of 992 hyperthyroid patients in France","volume":"6","author":"Goichot","year":"2017","journal-title":"Eur Thyroid J"},{"key":"10.1016\/j.ando.2018.08.002_bib0335","doi-asserted-by":"crossref","DOI":"10.1159\/000490384","article-title":"2018 European Thyroid Association guideline for the management of Graves\u2019 hyperthyroidism","author":"Kahaly","year":"2018","journal-title":"Eur Thyroid J"},{"issue":"6","key":"10.1016\/j.ando.2018.08.002_bib0340","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1515\/cclm-2016-1183","article-title":"High-dose biotin therapy leading to false biochemical endocrine profiles: validation of a simple method to overcome biotin interference","volume":"55","author":"Piketty","year":"2017","journal-title":"Clin Chem Lab Med"}],"container-title":["Annales d'Endocrinologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426618312150?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426618312150?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,8]],"date-time":"2020-11-08T00:03:39Z","timestamp":1604793819000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003426618312150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S0003426618312150"],"URL":"https:\/\/doi.org\/10.1016\/j.ando.2018.08.002","relation":{},"ISSN":["0003-4266"],"issn-type":[{"value":"0003-4266","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic procedure in suspected Graves\u2019 disease","name":"articletitle","label":"Article Title"},{"value":"Annales d'Endocrinologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2018.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}